COMMUNIQUÉS West-GlobeNewswire

Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering
09/10/2025
SAN FRANCISCO and BOSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles [...]
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/10/2025
DELRAY BEACH, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS), today announced that on September 9, 2025, the Compensation and [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
08/10/2025
ZUG, Switzerland, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company. Attachment Notification of managers' [...]
BrightSpring Health Services, Inc. to Announce Third Quarter 2025 Financial Results on October 31, 2025
08/10/2025
LOUISVILLE, Ky., Oct. 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2025 financial results on [...]
Dentsply Sirona to Host Third Quarter Conference Call on November 6th
08/10/2025
CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on [...]
AMN Healthcare to Hold Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025
08/10/2025
DALLAS, Oct. 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its third quarter 2025 financial results and fourth quarter 2025 outlook on Thursday, [...]
Greenspace Herbs Unveils Physics-Driven Quantum Ayurveda at SupplySide Global
08/10/2025
BANGALORE, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Greenspace Herbs , a botanical science company merging ancient Ayurveda with quantum physics, will debut its Quantum Ayurveda™ technology during a live demonstration [...]
Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
08/10/2025
Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.20-0.51; p<0. [...]
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
08/10/2025
SAN FRANCISCO and BOSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles [...]
Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon® CNP for Treatment of Children with Achondroplasia
08/10/2025
COPENHAGEN, Denmark, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TransCon [...]
Medicare Now Reimbursing for EnteroTrack’s Esophageal String Test®, Expanding Access to Patients with Eosinophilic Esophagitis
08/10/2025
AURORA, Colo., Oct. 08, 2025 (GLOBE NEWSWIRE) -- EnteroTrack LLC announced that the Centers for Medicare & Medicaid Services (CMS) is paying for the company’s Esophageal String Test ® (EST), marking a major [...]
Channel Medsystems Appoints Healthcare Executive Skip Baldino to Board of Directors
08/10/2025
BERKELEY, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women’s health with innovative solutions, announced today the appointment of Skip Baldino to [...]
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
08/10/2025
HUNTSVILLE, AL., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology [...]
Tessera Therapeutics Awarded up to $41.3 Million from ARPA-H to Advance In Vivo CAR-T Therapies
08/10/2025
Award will support development of a single dose in vivo chimeric antigen receptor T cell (CAR-T) therapy to retrain immune cells directly within the body to fight cancer and autoimmune diseases using Tessera’s Gene [...]
Protext Mobility, Inc. (OTC: TXTM) Announces New Member of Its Advisory Board
08/10/2025
WILMINGTON, Del., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM), an emerging innovator in the biotechnology and alternative wellness sector, today announced the first members of its Advisory Board [...]
Unyte Health Celebrates 10 Years as the Leader in Nervous System Regulation and Sound-Based Listening Therapies
08/10/2025
DENVER, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ten years, 10,000 trained providers, and over 100,000 lives transformed: Unyte Health celebrates a decade of pioneering sound-based interventions that bring the science of [...]
Turn Therapeutics to Commence Trading Today on Nasdaq
08/10/2025
Founder & CEO, Bradley Burnam, to Ring NASDAQ “Closing Bell” at 4:00 PM ET WESTLAKE VILLAGE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (“Turn” or the “Company”), a clinical-stage biotechnology [...]
Ashvattha Therapeutics to Present Phase 2 DME and nAMD Data at Innovate Retina
08/10/2025
Migaldendranib (MGB), a subcutaneous nanomedicine, represents potential paradigm shift from frequent intravitreal injections REDWOOD CITY, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), [...]
ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® (epinephrine nasal spray)
08/10/2025
SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect [...]

Pages